A human leucyl-tRNA synthetase as an anticancer target.
Several aminoacyl-tRNA synthetases have been reported to be overexpressed for charging essential aminoacyl-tRNAs in many cancer types. In this study, we aimed to explore the potential role of leucyl-tRNA synthetase (LARS) as an anticancer target. MTT assay was performed to screen inhibitors to human LARS (hsLARS) from compounds AN2690 and its derivatives, compounds 1-6, in U2OS and SKOV3 cells. The compound with the strongest inhibitory ability was further investigated for its inhibitory effect in cancer cell lines and in an animal tumor model. Additionally, a LARS-rescue experiment was performed to explore the potential target in U2OS using Western blot and flow cytometry. Luciferase reporter assay was designed to analyze the effect of of hsLARS inhibitor on p21 activation. We identified an hsLARS inhibitor (compound 2) that suppressed the proliferation of U2OS and SKOV3 cells in vitro. A LARS-rescue experiment demonstrated that the proliferation inhibition was induced by targeting intracellular LARS. In addition, the hsLARS inhibition was shown to activate the p21 early transcription and promote cell apoptosis, as well as reduce implanted EMT6 tumor progression in mice. Our results suggest that LARS might serve as a potential anticancer target through the p21 signaling pathway and that the nutritional signaling pathway may provide a valuable anticancer strategy for further investigation.
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Guangwei
G
Gao
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Ying
Y
Yao
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Kun
K
Li
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Dhahiri Saidi
DS
Mashausi
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Dongsheng
D
Li
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Hema
H
Negi
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Suchitra
S
Kamle
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Hao
H
Chen
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Zhenghua
Z
Wu
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Huchen
H
Zhou
School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Dawei
D
Li
anticancer target; apoptosis; leucyl-tRNA synthetase; mouse model